Top compounds associated with response to RPL9


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine gCSI pan-cancer AAC 0.17 0.002
mRNA chlorambucil CTRPv2 pan-cancer AAC 0.11 0.002
mRNA OSI-027 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.12 0.002
mRNA paclitaxel gCSI pan-cancer AAC 0.16 0.002
mRNA Vinorelbine GDSC1000 pan-cancer AAC 0.12 0.002
mRNA Talazoparib GDSC1000 pan-cancer AAC 0.11 0.002
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.12 0.002
mRNA Docetaxel gCSI pan-cancer AAC 0.16 0.002
mRNA DBeQ CTRPv2 pan-cancer AAC -0.13 0.002
Download CSV